Mixed bullous disease.
D000293:Adolescent; D000368:Aged; D000906:Antibodies / Q000032:analysis; D001768:Blister / Q000473:pathology; D003622:Dapsone / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D010392:Pemphigus / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D012867:Skin / Q000473:pathology; D013450:Sulfones / Q000627:therapeutic use
D000906:Antibodies; D007074:Immunoglobulin G; D013450:Sulfones; D003622:Dapsone; D011241:Prednisone